The 2nd stock is a generic drug company Endo Pharmaceuticals (ENDP). The weekly chart showed RSI bottom divergence. It is positive sign that this stock will move up. So far the price still runs inside a falling wedge unless it can break out the wedge before running into the end of wedge. The optimal buy entry is the end of falling wedge, if break out earlier, have to chase. Upside target is $25.
The 3rd one is ACIA. The stock price recently is quite positive. It is ready to challenge the upsdie 50 days MA around $67.
The 4th one is Nuance Cimmunications (NUAN). Positive stock price action recently put multiple short term MAs underneath as support. 50 days MA is ready to cross up 200 days MA, upside target is around $17~$17.5.
The 5th is Teva Pharmaceuticals (TEVA). The stock price is in down trend for a long while, kind of depressing. However, sometimes depressing price may give buyers a good deal for long term hold. The price just sit on the monthly multiple support around level 31~33. The monthly RSI showed extremely over sold. If it hold level 31~33, it will back up; if not, next level support is 25. The patient stock holder can take average down approach to get in some at $31~33, and some at $25 (if break down current level).
http://schrts.co/u6mdJr
The sixth one is SRPT. I have played this stock in last December. The run was from below $30 to $38. Now the price back down. The price is close to the support level around $28.8 again. This level should be watched for rebound. Note: the comments on the chart is still from last December.
http://schrts.co/jzZv61
The last one is popular BABA. The price action is pretty positive recently. The bias is still going up if there is no earning report immediately. The earning sometimes is disruptive and unpredictable. So the short term upside target is based on no earning's disturbance.
In summary, I have not make any decision to get in either one of these stocks. The analysis is for the evaluation purpose.
No comments:
Post a Comment